HK Stock MarketDetailed Quotes
01061 ESSEX BIO-TECH
- 2.750
- -0.070-2.48%
Market Closed Dec 18 16:08 CST
1.56BMarket Cap5.94P/E (TTM)
2.790High2.700Low583.00KVolume2.750Open2.820Pre Close1.59MTurnover0.10%Turnover Ratio5.67P/E (Static)567.29MShares3.10052wk High0.77P/B1.56BFloat Cap1.85552wk Low0.11Dividend TTM567.29MShs Float9.067Historical High0.090Dividend LFY3.19%Amplitude-0.627Historical Low2.719Avg Price1000Lot Size3.82%Div YieldTTM3.27%Div Yield LFY
About ESSEX BIO-TECH Company
Yisheng Biotechnology Co., Ltd. (“Essex Biotech Group and Company”) was incorporated in the Cayman Islands on July 31, 2000, and listed on the Hong Kong Stock Exchange on June 27, 2001. The Group's main business is the manufacture and sale of biopharmaceuticals to treat surface trauma and eye damage. In addition, it is also engaged in the development of bFGF drugs and other eye drug projects for new indications. The Group has now successfully developed a series of genetically-engineered biopharmaceuticals. Three of these products have also been classified as new national Class I drugs. The main brands are Beifuji, Beifusu, and Beifuxin.
Company Profile
Symbol01061
Company NameESSEX BIO-TECH
ISINKYG312371035
Listing DateJun 23, 2011
Registered AddressCayman Islands
Chairmanmingchi yan
Secretaryliwen qiu
Audit InstitutionHong Kong Lixin Dehao Certified Public Accountants Limited
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong
Fiscal Year Ends12-31
Employees1459
MarketHong Kong motherboard
Phone(+852) 2587 7838
Fax(+852) 2587 7363
Emailessex@essexbio.com
Websitehttp://www.essexbio.com
Business Yisheng Biotechnology Co., Ltd. is an investment holding company mainly engaged in the production and sale of biopharmaceuticals for the treatment of surface trauma and eye damage. The company develops biopharmaceuticals based on recombinant DNA technology. The company's main brands are Beifu, Beifu, and Beifuxin. The company operates through two business segments. The Pharmaceutical Division is engaged in the manufacture and sale of pharmaceuticals. The Marketing Services Division is engaged in the distribution and promotion of third-party pharmaceutical products.
Company Executives
- Name
- Position
- Salary
- mingchi yan
- Presidencies, Executive Director, Remuneration Committee Members, Nomination Committee Members
- --
- haizhou fang
- Executive Director, Managing Director, Authorized Representative
- --
- xianlong yan
- Executive Director, Deputy Managing Director of the Company
- --
- liwen qiu
- Executive Director, Qualified Accountants, Authorized Representative, Company Secretary
- --
- zhiying feng
- Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
- --
- wenxing zhen
- Independent Non-Executive Director, Remuneration Committee Members, Nomination Committee Members, Audit Committee Members
- 128.33K
- meimei qiu
- Independent Non-Executive Director, Chairman of the Nomination Committee, Remuneration Committee Chairman, Audit Committee Members
- --
- qi xue
- Chief Scientist
- --
- zanshun zheng
- Director of Zhuhai Yisheng Biotechnology Co., Ltd., Managing Director of Zhuhai Yisheng Biopharmaceutical Co., Ltd., Managing Director of Zhuhai Yisheng Pharmaceutical Co., Ltd.
- --
Heat List
HK
Overall
Symbol
Price
% Chg
No Data